APO Research
Talk to an analyst

APO RESEARCH · REPORT

Cholera Vaccine (Oral Route)

Compare research editions
View pricing & licenses

Selected research

Market Structure

Global Cholera Vaccine (Oral Route) Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032

26 December 2025174 pages

Choose your research edition.

Industry ResearchCholera Vaccine (Oral Route) Industry Research Report 2026109 pages · $2,950 USDIndustry Growth & TrendsGlobal Cholera Vaccine (Oral Route) Industry Growth and Trends Forecast to 203279 pages · $3,450 USDMarket StructureGlobal Cholera Vaccine (Oral Route) Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032174 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Cholera Vaccine (Oral Route) Market Outlook and Growth Opportunities 2026198 pages · $4,250 USDMarket Analysis & ForecastGlobal Cholera Vaccine (Oral Route) Market Analysis and Forecast 2026-2032192 pages · $4,950 USD

Market perspective

The global Cholera Vaccine (Oral Route) market is projected to grow from US$ million in 2026 to US$ million by 2032, implying a CAGR of % over 2026-2032.

The US & Canada market for Cholera Vaccine (Oral Route) is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Cholera Vaccine (Oral Route) is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Cholera Vaccine (Oral Route) is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The China market for Cholera Vaccine (Oral Route) is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Cholera Vaccine (Oral Route) include EuBiologics, PaxVax, Valneva and Sanofi, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Cholera Vaccine (Oral Route) market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Cholera Vaccine (Oral Route) and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Cholera Vaccine (Oral Route) sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Cholera Vaccine (Oral Route) market size, projected growth trends, production technologies, key applications, and end-use industries.

Cholera Vaccine (Oral Route) Segment by Company

EuBiologics

PaxVax

Valneva

Sanofi

Cholera Vaccine (Oral Route) Segment by Type

Dukoral

Shanchol

Vaxchora

Others

Cholera Vaccine (Oral Route) Segment by Application

Pharmaceutical & Biotechnology Companies

Hospital

Research & Academic Laboratories

Others

Cholera Vaccine (Oral Route) Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Cholera Vaccine (Oral Route) market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Cholera Vaccine (Oral Route) and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Cholera Vaccine (Oral Route).

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Cholera Vaccine (Oral Route) market, including product definition, global market growth prospects, market size, sales, and average price forecasts (2021-2032).

Chapter 2: Provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Cholera Vaccine (Oral Route) manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales of Cholera Vaccine (Oral Route) in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 7: Revenue of Cholera Vaccine (Oral Route) in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights of the report

More report detail

Tables and figures
List of Tables Table 1. Cholera Vaccine (Oral Route) Industry Trends Table 2. Cholera Vaccine (Oral Route) Industry Drivers Table 3. Cholera Vaccine (Oral Route) Industry Opportunities and Challenges Table 4. Cholera Vaccine (Oral Route) Industry Restraints Table 5. Global Cholera Vaccine (Oral Route) Revenue by Manufacturers (US$ Million) & (2021-2026) Table 6. Global Cholera Vaccine (Oral Route) Revenue Market Share by Manufacturers (2021-2026) Table 7. Global Cholera Vaccine (Oral Route) Sales by Manufacturers (K Units) & (2021-2026) Table 8. Global Cholera Vaccine (Oral Route) Sales Market Share by Manufacturers Table 9. Global Cholera Vaccine (Oral Route) Average Sales Price (US$/Unit) of Manufacturers (2021-2026) Table 10. Global Cholera Vaccine (Oral Route) Industry Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 11. Global Cholera Vaccine (Oral Route) Key Manufacturers Manufacturing Sites & Headquarters Table 12. Global Cholera Vaccine (Oral Route) Manufacturers, Product Type & Application Table 13. Global Cholera Vaccine (Oral Route) Manufacturers Establishment Date Table 14. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 15. Global Cholera Vaccine (Oral Route) by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2025) Table 16. Major Manufacturers of Dukoral Table 17. Major Manufacturers of Shanchol Table 18. Major Manufacturers of Vaxchora Table 19. Major Manufacturers of Others Table 20. Global Cholera Vaccine (Oral Route) Sales by Type 2021 VS 2025 VS 2032 (K Units) Table 21. Global Cholera Vaccine (Oral Route) Sales by Type (2021-2026) & (K Units) Table 22. Global Cholera Vaccine (Oral Route) Sales by Type (2027-2032) & (K Units) Table 23. Global Cholera Vaccine (Oral Route) Sales Market Share by Type (2021-2026) Table 24. Global Cholera Vaccine (Oral Route) Sales Market Share by Type (2027-2032) Table 25. Global Cholera Vaccine (Oral Route) Revenue by Type 2021 VS 2025 VS 2032 (K Units) Table 26. Global Cholera Vaccine (Oral Route) Revenue by Type (2021-2026) & (K Units) Table 27. Global Cholera Vaccine (Oral Route) Revenue by Type (2027-2032) & (K Units) Table 28. Global Cholera Vaccine (Oral Route) Revenue Market Share by Type (2021-2026) Table 29. Global Cholera Vaccine (Oral Route) Revenue Market Share by Type (2027-2032) Table 30. Major Manufacturers of Pharmaceutical & Biotechnology Companies Table 31. Major Manufacturers of Hospital Table 32. Major Manufacturers of Research & Academic Laboratories Table 33. Major Manufacturers of Others Table 34. Global Cholera Vaccine (Oral Route) Sales by Application 2021 VS 2025 VS 2032 (K Units) Table 35. Global Cholera Vaccine (Oral Route) Sales by Application (2021-2026) & (K Units) Table 36. Global Cholera Vaccine (Oral Route) Sales by Application (2027-2032) & (K Units) Table 37. Global Cholera Vaccine (Oral Route) Sales Market Share by Application (2021-2026) Table 38. Global Cholera Vaccine (Oral Route) Sales Market Share by Application (2027-2032) Table 39. Global Cholera Vaccine (Oral Route) Revenue by Application 2021 VS 2025 VS 2032 (K Units) Table 40. Global Cholera Vaccine (Oral Route) Revenue by Application (2021-2026) & (K Units) Table 41. Global Cholera Vaccine (Oral Route) Revenue by Application (2027-2032) & (K Units) Table 42. Global Cholera Vaccine (Oral Route) Revenue Market Share by Application (2021-2026) Table 43. Global Cholera Vaccine (Oral Route) Revenue Market Share by Application (2027-2032) Table 44. Global Cholera Vaccine (Oral Route) Sales by Region: 2021 VS 2025 VS 2032 (K Units) Table 45. Global Cholera Vaccine (Oral Route) Sales by Region (2021-2026) & (K Units) Table 46. Global Cholera Vaccine (Oral Route) Sales Market Share by Region (2021-2026) Table 47. Global Cholera Vaccine (Oral Route) Sales Forecasted by Region (2027-2032) & (K Units) Table 48. Global Cholera Vaccine (Oral Route) Sales Forecasted Market Share by Region (2027-2032) Table 49. North America Cholera Vaccine (Oral Route) Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 50. North America Cholera Vaccine (Oral Route) Sales by Country (2021-2026) & (K Units) Table 51. North America Cholera Vaccine (Oral Route) Sales by Country (2027-2032) & (K Units) Table 52. Europe Cholera Vaccine (Oral Route) Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 53. Europe Cholera Vaccine (Oral Route) Sales by Country (2021-2026) & (K Units) Table 54. Europe Cholera Vaccine (Oral Route) Sales by Country (2027-2032) & (K Units) Table 55. Asia Pacific Cholera Vaccine (Oral Route) Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 56. Asia Pacific Cholera Vaccine (Oral Route) Sales by Country (2021-2026) & (K Units) Table 57. Asia Pacific Cholera Vaccine (Oral Route) Sales by Country (2027-2032) & (K Units) Table 58. South America, Middle East and Africa Cholera Vaccine (Oral Route) Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 59. South America, Middle East and Africa Cholera Vaccine (Oral Route) Sales by Country (2021-2026) & (K Units) Table 60. South America, Middle East and Africa Cholera Vaccine (Oral Route) Sales by Country (2027-2032) & (K Units) Table 61. Global Cholera Vaccine (Oral Route) Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 62. Global Cholera Vaccine (Oral Route) Revenue by Region (2021-2026) & (US$ Million) Table 63. Global Cholera Vaccine (Oral Route) Revenue by Region (2027-2032) & (US$ Million) Table 64. Global Cholera Vaccine (Oral Route) Revenue Market Share by Region (2021-2026) Table 65. Global Cholera Vaccine (Oral Route) Revenue Market Share by Region (2027-2032) Table 66. EuBiologics Company Information Table 67. EuBiologics Business Overview Table 68. EuBiologics Cholera Vaccine (Oral Route) Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 69. EuBiologics Cholera Vaccine (Oral Route) Product Portfolio Table 70. EuBiologics Recent Development Table 71. PaxVax Company Information Table 72. PaxVax Business Overview Table 73. PaxVax Cholera Vaccine (Oral Route) Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 74. PaxVax Cholera Vaccine (Oral Route) Product Portfolio Table 75. PaxVax Recent Development Table 76. Valneva Company Information Table 77. Valneva Business Overview Table 78. Valneva Cholera Vaccine (Oral Route) Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 79. Valneva Cholera Vaccine (Oral Route) Product Portfolio Table 80. Valneva Recent Development Table 81. Sanofi Company Information Table 82. Sanofi Business Overview Table 83. Sanofi Cholera Vaccine (Oral Route) Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 84. Sanofi Cholera Vaccine (Oral Route) Product Portfolio Table 85. Sanofi Recent Development Table 86. Key Raw Materials Table 87. Raw Materials Key Suppliers Table 88. Cholera Vaccine (Oral Route) Distributors List Table 89. Cholera Vaccine (Oral Route) Customers List Table 90. Research Programs/Design for This Report Table 91. Authors List of This Report Table 92. Secondary Sources Table 93. Primary Sources List of Figures Figure 1. Cholera Vaccine (Oral Route) Product Image Figure 2. Global Cholera Vaccine (Oral Route) Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Cholera Vaccine (Oral Route) Market Size (2021-2032) & (US$ Million) Figure 4. Global Cholera Vaccine (Oral Route) Sales (2021-2032) & (K Units) Figure 5. Global Cholera Vaccine (Oral Route) Average Price (US$/Unit) & (2021-2032) Figure 6. Global Top 5 and 10 Cholera Vaccine (Oral Route) Players Market Share by Revenue in 2025 Figure 7. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 8. Dukoral Image Figure 9. Shanchol Image Figure 10. Vaxchora Image Figure 11. Others Image Figure 12. Global Cholera Vaccine (Oral Route) Sales by Type (2021 VS 2025 VS 2032) & (K Units) Figure 13. Global Cholera Vaccine (Oral Route) Sales Market Share 2021 VS 2025 VS 2032 Figure 14. Global Cholera Vaccine (Oral Route) Sales Market Share by Type (2021-2032) Figure 15. Global Cholera Vaccine (Oral Route) Revenue by Type (2021 VS 2025 VS 2032) & (K Units) Figure 16. Global Cholera Vaccine (Oral Route) Revenue Market Share 2021 VS 2025 VS 2032 Figure 17. Global Cholera Vaccine (Oral Route) Revenue Market Share by Type (2021-2032) Figure 18. Pharmaceutical & Biotechnology Companies Image Figure 19. Hospital Image Figure 20. Research & Academic Laboratories Image Figure 21. Others Image Figure 22. Global Cholera Vaccine (Oral Route) Sales by Application (2021 VS 2025 VS 2032) & (K Units) Figure 23. Global Cholera Vaccine (Oral Route) Sales Market Share 2021 VS 2025 VS 2032 Figure 24. Global Cholera Vaccine (Oral Route) Sales Market Share by Application (2021-2032) Figure 25. Global Cholera Vaccine (Oral Route) Revenue by Application (2021 VS 2025 VS 2032) & (K Units) Figure 26. Global Cholera Vaccine (Oral Route) Revenue Market Share 2021 VS 2025 VS 2032 Figure 27. Global Cholera Vaccine (Oral Route) Revenue Market Share by Application (2021-2032) Figure 28. North America Cholera Vaccine (Oral Route) Sales and Growth Rate (2021-2032) & (K Units) Figure 29. North America Cholera Vaccine (Oral Route) Sales Market Share by Country (2021-2032) Figure 30. U.S. Cholera Vaccine (Oral Route) Sales and Growth Rate (2021-2032) & (K Units) Figure 31. Canada Cholera Vaccine (Oral Route) Sales and Growth Rate (2021-2032) & (K Units) Figure 32. Mexico Cholera Vaccine (Oral Route) Sales and Growth Rate (2021-2032) & (K Units) Figure 33. Europe Cholera Vaccine (Oral Route) Sales and Growth Rate (2021-2032) & (K Units) Figure 34. Europe Cholera Vaccine (Oral Route) Sales Market Share by Country (2021-2032) Figure 35. Germany Cholera Vaccine (Oral Route) Sales and Growth Rate (2021-2032) & (K Units) Figure 36. France Cholera Vaccine (Oral Route) Sales and Growth Rate (2021-2032) & (K Units) Figure 37. U.K. Cholera Vaccine (Oral Route) Sales and Growth Rate (2021-2032) & (K Units) Figure 38. Italy Cholera Vaccine (Oral Route) Sales and Growth Rate (2021-2032) & (K Units) Figure 39. Netherlands Cholera Vaccine (Oral Route) Sales and Growth Rate (2021-2032) & (K Units) Figure 40. Asia Pacific Cholera Vaccine (Oral Route) Sales and Growth Rate (2021-2032) & (K Units) Figure 41. Asia Pacific Cholera Vaccine (Oral Route) Sales Market Share by Country (2021-2032) Figure 42. China Cholera Vaccine (Oral Route) Sales and Growth Rate (2021-2032) & (K Units) Figure 43. Japan Cholera Vaccine (Oral Route) Sales and Growth Rate (2021-2032) & (K Units) Figure 44. South Korea Cholera Vaccine (Oral Route) Sales and Growth Rate (2021-2032) & (K Units) Figure 45. Southeast Asia Cholera Vaccine (Oral Route) Sales and Growth Rate (2021-2032) & (K Units) Figure 46. India Cholera Vaccine (Oral Route) Sales and Growth Rate (2021-2032) & (K Units) Figure 47. Australia Cholera Vaccine (Oral Route) Sales and Growth Rate (2021-2032) & (K Units) Figure 48. South America, Middle East and Africa Cholera Vaccine (Oral Route) Sales and Growth Rate (2021-2032) & (K Units) Figure 49. South America, Middle East and Africa Cholera Vaccine (Oral Route) Sales Market Share by Country (2021-2032) Figure 50. Brazil Cholera Vaccine (Oral Route) Sales and Growth Rate (2021-2032) & (K Units) Figure 51. South Africa Cholera Vaccine (Oral Route) Sales and Growth Rate (2021-2032) & (K Units) Figure 52. Saudi Arabia Cholera Vaccine (Oral Route) Sales and Growth Rate (2021-2032) & (K Units) Figure 53. Turkey Cholera Vaccine (Oral Route) Sales and Growth Rate (2021-2032) & (K Units) Figure 54. Argentina Cholera Vaccine (Oral Route) Sales and Growth Rate (2021-2032) & (K Units) Figure 55. UAE Cholera Vaccine (Oral Route) Sales and Growth Rate (2021-2032) & (K Units) Figure 56. Egypt Cholera Vaccine (Oral Route) Sales and Growth Rate (2021-2032) & (K Units) Figure 57. Chile Cholera Vaccine (Oral Route) Sales and Growth Rate (2021-2032) & (K Units) Figure 58. Global Cholera Vaccine (Oral Route) Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 59. Global Cholera Vaccine (Oral Route) Revenue Market Share by Region in Percentage: 2025 Versus 2032 Figure 60. North America Cholera Vaccine (Oral Route) Revenue (2021-2032) & (US$ Million) Figure 61. North America Cholera Vaccine (Oral Route) Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 62. Europe Cholera Vaccine (Oral Route) Revenue (2021-2032) & (US$ Million) Figure 63. Europe Cholera Vaccine (Oral Route) Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 64. Asia-Pacific Cholera Vaccine (Oral Route) Revenue (2021-2032) & (US$ Million) Figure 65. Asia-Pacific Cholera Vaccine (Oral Route) Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 66. South America, Middle East and Africa Cholera Vaccine (Oral Route) Revenue (2021-2032) & (US$ Million) Figure 67. South America, Middle East and Africa Cholera Vaccine (Oral Route) Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 68. Cholera Vaccine (Oral Route) Value Chain Figure 69. Manufacturing Cost Structure Figure 70. Cholera Vaccine (Oral Route) Production Mode & Process Figure 71. Direct Comparison with Distribution Share Figure 72. Distributors Profiles Figure 73. Years Considered Figure 74. Research Process Figure 75. Key Executives Interviewed

Scope & coverage.

Types
  • Dukoral
  • Shanchol
  • Vaxchora
  • Others
Applications
  • Pharmaceutical & Biotechnology Companies
  • Hospital
  • Research & Academic Laboratories
  • Others
Companies covered
  • EuBiologics
  • PaxVax
  • Valneva
  • Sanofi

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Cholera Vaccine (Oral Route) Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global Cholera Vaccine (Oral Route) Market Size Estimates and Forecasts (2021-2032)
  4. 1.4 Global Cholera Vaccine (Oral Route) Sales Estimates and Forecasts (2021-2032)
  5. 1.5 Global Cholera Vaccine (Oral Route) Market Average Price (2021-2032)
  6. 1.6 Assumptions and Limitations
  7. 1.7 Study Goals and Objectives
2 Global Cholera Vaccine (Oral Route) Market Dynamics
  1. 2.1 Cholera Vaccine (Oral Route) Industry Trends
  2. 2.2 Cholera Vaccine (Oral Route) Industry Drivers
  3. 2.3 Cholera Vaccine (Oral Route) Industry Opportunities and Challenges
  4. 2.4 Cholera Vaccine (Oral Route) Industry Restraints
3 Cholera Vaccine (Oral Route) Market by Manufacturers
  1. 3.1 Global Cholera Vaccine (Oral Route) Revenue by Manufacturers (2021-2026)
  2. 3.2 Global Cholera Vaccine (Oral Route) Sales by Manufacturers (2021-2026)
  3. 3.3 Global Cholera Vaccine (Oral Route) Average Sales Price by Manufacturers (2021-2026)
  4. 3.4 Global Cholera Vaccine (Oral Route) Industry Manufacturers Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Cholera Vaccine (Oral Route) Key Manufacturers Manufacturing Sites & Headquarters
  6. 3.6 Global Cholera Vaccine (Oral Route) Manufacturers, Product Type & Application
  7. 3.7 Global Cholera Vaccine (Oral Route) Manufacturers Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Cholera Vaccine (Oral Route) Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Cholera Vaccine (Oral Route) Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Cholera Vaccine (Oral Route) Tier 1, Tier 2, and Tier 3
4 Cholera Vaccine (Oral Route) Market by Type
  1. 4.1 Cholera Vaccine (Oral Route) Type Introduction
  2. 4.1.1 Dukoral
  3. 4.1.2 Shanchol
  4. 4.1.3 Vaxchora
  5. 4.1.4 Others
  6. 4.2 Global Cholera Vaccine (Oral Route) Sales by Type
  7. 4.2.1 Global Cholera Vaccine (Oral Route) Sales by Type (2021 VS 2025 VS 2032)
  8. 4.2.2 Global Cholera Vaccine (Oral Route) Sales by Type (2021-2032)
  9. 4.2.3 Global Cholera Vaccine (Oral Route) Sales Market Share by Type (2021-2032)
  10. 4.3 Global Cholera Vaccine (Oral Route) Revenue by Type
  11. 4.3.1 Global Cholera Vaccine (Oral Route) Revenue by Type (2021 VS 2025 VS 2032)
  12. 4.3.2 Global Cholera Vaccine (Oral Route) Revenue by Type (2021-2032)
  13. 4.3.3 Global Cholera Vaccine (Oral Route) Revenue Market Share by Type (2021-2032)
5 Cholera Vaccine (Oral Route) Market by Application
  1. 5.1 Cholera Vaccine (Oral Route) Application Introduction
  2. 5.1.1 Pharmaceutical & Biotechnology Companies
  3. 5.1.2 Hospital
  4. 5.1.3 Research & Academic Laboratories
  5. 5.1.4 Others
  6. 5.2 Global Cholera Vaccine (Oral Route) Sales by Application
  7. 5.2.1 Global Cholera Vaccine (Oral Route) Sales by Application (2021 VS 2025 VS 2032)
  8. 5.2.2 Global Cholera Vaccine (Oral Route) Sales by Application (2021-2032)
  9. 5.2.3 Global Cholera Vaccine (Oral Route) Sales Market Share by Application (2021-2032)
  10. 5.3 Global Cholera Vaccine (Oral Route) Revenue by Application
  11. 5.3.1 Global Cholera Vaccine (Oral Route) Revenue by Application (2021 VS 2025 VS 2032)
  12. 5.3.2 Global Cholera Vaccine (Oral Route) Revenue by Application (2021-2032)
  13. 5.3.3 Global Cholera Vaccine (Oral Route) Revenue Market Share by Application (2021-2032)
6 Global Cholera Vaccine (Oral Route) Sales by Region
  1. 6.1 Global Cholera Vaccine (Oral Route) Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Cholera Vaccine (Oral Route) Sales by Region (2021-2032)
  3. 6.2.1 Global Cholera Vaccine (Oral Route) Sales by Region (2021-2026)
  4. 6.2.2 Global Cholera Vaccine (Oral Route) Sales Forecasted by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America Cholera Vaccine (Oral Route) Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  7. 6.3.2 North America Cholera Vaccine (Oral Route) Sales by Country (2021-2032)
  8. 6.3.3 U.S.
  9. 6.3.4 Canada
  10. 6.3.5 Mexico
  11. 6.4 Europe
  12. 6.4.1 Europe Cholera Vaccine (Oral Route) Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  13. 6.4.2 Europe Cholera Vaccine (Oral Route) Sales by Country (2021-2032)
  14. 6.4.3 Germany
  15. 6.4.4 France
  16. 6.4.5 U.K.
  17. 6.4.6 Italy
  18. 6.4.7 Netherlands
  19. 6.5 Asia Pacific
  20. 6.5.1 Asia Pacific Cholera Vaccine (Oral Route) Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  21. 6.5.2 Asia Pacific Cholera Vaccine (Oral Route) Sales by Country (2021-2032)
  22. 6.5.3 China
  23. 6.5.4 Japan
  24. 6.5.5 South Korea
  25. 6.5.6 Southeast Asia
  26. 6.5.7 India
  27. 6.5.8 Australia
  28. 6.6 South America, Middle East and Africa
  29. 6.6.1 South America, Middle East and Africa Cholera Vaccine (Oral Route) Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  30. 6.6.2 South America, Middle East and Africa Cholera Vaccine (Oral Route) Sales by Country (2021-2032)
  31. 6.6.3 Brazil
  32. 6.6.4 South Africa
  33. 6.6.5 Saudi Arabia
  34. 6.6.6 Turkey
  35. 6.6.6 Argentina
  36. 6.6.6 UAE
  37. 6.6.6 Egypt
  38. 6.6.6 Chile
7 Global Cholera Vaccine (Oral Route) Revenue by Region
  1. 7.1 Global Cholera Vaccine (Oral Route) Revenue by Region
  2. 7.1.1 Global Cholera Vaccine (Oral Route) Revenue by Region: 2021 VS 2025 VS 2032
  3. 7.1.2 Global Cholera Vaccine (Oral Route) Revenue by Region (2021-2026)
  4. 7.1.3 Global Cholera Vaccine (Oral Route) Revenue by Region (2027-2032)
  5. 7.1.4 Global Cholera Vaccine (Oral Route) Revenue Market Share by Region (2021-2032)
  6. 7.2 North America
  7. 7.2.1 North America Cholera Vaccine (Oral Route) Revenue (2021-2032)
  8. 7.2.2 North America Cholera Vaccine (Oral Route) Revenue Share by Country: 2021 VS 2025 VS 2032
  9. 7.3 Europe
  10. 7.3.1 Europe Cholera Vaccine (Oral Route) Revenue (2021-2032)
  11. 7.3.2 Europe Cholera Vaccine (Oral Route) Revenue Share by Country: 2021 VS 2025 VS 2032
  12. 7.4 Asia-Pacific
  13. 7.4.1 Asia-Pacific Cholera Vaccine (Oral Route) Revenue (2021-2032)
  14. 7.4.2 Asia-Pacific Cholera Vaccine (Oral Route) Revenue Share by Country: 2021 VS 2025 VS 2032
  15. 7.5 South America, Middle East and Africa
  16. 7.5.1 South America, Middle East and Africa Cholera Vaccine (Oral Route) Revenue (2021-2032)
  17. 7.5.2 South America, Middle East and Africa Cholera Vaccine (Oral Route) Revenue Share by Country: 2021 VS 2025 VS 2032
8 Company Profiles
  1. 8.1 EuBiologics
  2. 8.1.1 EuBiologics Company Information
  3. 8.1.2 EuBiologics Business Overview
  4. 8.1.3 EuBiologics Cholera Vaccine (Oral Route) Sales, Price, Revenue and Gross Margin (2021-2026)
  5. 8.1.4 EuBiologics Cholera Vaccine (Oral Route) Product Portfolio
  6. 8.1.5 EuBiologics Recent Developments
  7. 8.2 PaxVax
  8. 8.2.1 PaxVax Company Information
  9. 8.2.2 PaxVax Business Overview
  10. 8.2.3 PaxVax Cholera Vaccine (Oral Route) Sales, Price, Revenue and Gross Margin (2021-2026)
  11. 8.2.4 PaxVax Cholera Vaccine (Oral Route) Product Portfolio
  12. 8.2.5 PaxVax Recent Developments
  13. 8.3 Valneva
  14. 8.3.1 Valneva Company Information
  15. 8.3.2 Valneva Business Overview
  16. 8.3.3 Valneva Cholera Vaccine (Oral Route) Sales, Price, Revenue and Gross Margin (2021-2026)
  17. 8.3.4 Valneva Cholera Vaccine (Oral Route) Product Portfolio
  18. 8.3.5 Valneva Recent Developments
  19. 8.4 Sanofi
  20. 8.4.1 Sanofi Company Information
  21. 8.4.2 Sanofi Business Overview
  22. 8.4.3 Sanofi Cholera Vaccine (Oral Route) Sales, Price, Revenue and Gross Margin (2021-2026)
  23. 8.4.4 Sanofi Cholera Vaccine (Oral Route) Product Portfolio
  24. 8.4.5 Sanofi Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Cholera Vaccine (Oral Route) Value Chain Analysis
  2. 9.1.1 Cholera Vaccine (Oral Route) Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Cholera Vaccine (Oral Route) Production Mode & Process
  6. 9.2 Cholera Vaccine (Oral Route) Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Cholera Vaccine (Oral Route) Distributors
  9. 9.2.3 Cholera Vaccine (Oral Route) Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources
    8. 11.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst